Abstract:Aim To investigate the effects of rosiglitazone on the proliferation of vascular smooth muscle cells induced by angiotensinⅡ(AngⅡ) and possible mechanism. Methods Vascular smooth muscle cells(VSMC) were isolated from aortic media of four-week-old male Sprague-Dawley rats by enzymatic digestion and cultured in monolayer.VSMC in passage 4～8 in log phase were used in following experiments.VSMC were treated by 1 μmol/L AngⅡ for 6 h and randomly divided into the groups as follows: control group(10% FBS in DMEM),Ang Ⅱ group(1 μmol/L AngⅡ),groups respectively treated with different concentration of rosiglitazone(20,30,40 and 50 μmol/L) for 12 h and groups respectively treated with 30 μmol/L rosiglitazone for 6,12,18 and 24 h.The VSMC growth,change of proliferation cycle and mRNA and protein expression of AngⅡ type 2 receptor(AT2R) in all groups were detected by using MTT colorimetric assay,FCM,RT-PCR and Western blotting. Results The mean absorbance(A value) in the VSMC treated by AngⅡ was significantly higher as compared with that of the control group(P<0.01).The A values were markedly reduced in the VSMC treated by different concentration of rosiglitazone for 12 h or 30 μmol/L rosiglitazone for 6,12,18 and 24 h(P<0.05 or P<0.01).The proliferation index(PI) and S-phase fraction(SPF) in the AngⅡ group were significantly higher than those of the control group(P<0.01).With the increase in rosiglitazone concentration and prolongation of treatment time,PI and SPF were greatly reduced(P<0.05 or P<0.01).Compared with the AngⅡ group,expression of AT2R mRNA and protein in the VSMC with the treatment of 20,30 and 50 μmol/L rosiglitazone for 12 h or of 30 μmol/L rosiglitazone for 6,12 and 24 h were both markedly increased(P<0.05 or P<0.01),reaching a maximum in 50 μmol/L rosiglitazone for 12 h or 30 μmol/L rosiglitazone for 24 h. Conclusions Rosiglitazone inhibited VSMC proliferation induced by AngⅡ at least partially through up-regulating expression of AT2R both at mRNA and protein levels in a concentration-dependent and time-dependent manner,in order to play vasculoprotective role.

Rosiglitazone Inhibitory Effect on Mesangial Cell Proliferation and Extracellular Matrix Expression Induced by Angiotensin Ⅱ

Rosiglitazone ameliorates the dysfunction of endothelial progenitor cells induced by advanced glycation end products

A Ppar Gamma Agonist Inhibits Aldosterone-Induced Mesangial Cell Proliferation by Blocking Ros-Dependent Egfr Intracellular Signaling

Rosiglitazone Via Upregulation of Akt/Enos Pathways Attenuates Dysfunction of Endothelial Progenitor Cells, Induced by Advanced Glycation End Products

Rosiglitazone Inhibits Angiotensin II-Induced Proliferation of Glomerular Mesangial Cells Via the Gαq/Plcβ4/TRPC Signaling Pathway

Peroxisome Proliferator-Activated Receptor-Agonist Inhibited Angiotensin Ⅱ Induced Monocyte Chemoattractant Protein-1 Expression in Human Mesangial Cells

Rosiglitazone attenuates endothelial progenitor cell apoptosis induced by TNF-α via ERK/MAPK and NF-κB signal pathways.

Effects of Rosiglitazone on Proliferation of Vascular Smooth Muscle Cells Induced by Angiotensin Ⅱ

Effects of Rosiglitazone on the Expression of Angiotensin Ⅱ Type 1 Receptor and Type 2 Receptor in Angiotensin Ⅱ-Induced Mice Vascular Smooth Muscle Cells

Rosiglitazone Inhibits Angiotensin II-induced CTGF Expression in Vascular Smooth Muscle Cells––role of PPAR-γ in Vascular Fibrosis

Inhibitory Effects of Rosiglitazone on the Synthesis of Reactive Oxygen Species and the Expression of Monocyte Ehemoattractant Protein 1 in Rat Mesangial Cells Cultured in High Glucose

Inhibitory Effects of Rosiglitazone on the Expression of Transforming Growth Factor-β_1 in Rat Mesangial Cells Cultured in High Glucose

ROS-EGFR-JNK-AP-1 Signaling Pathway Involves in Angiotensin Ⅱ-induced Human Mesangial Cells Proliferation

Inhibitory effects of rosiglitazone and ciglitazone on rat aortic adventitial fibroblasts proliferation induced by angiotensin Ⅱ in vitro

Effects of rosiglitazone on rat aortic adventitial fibroblasts migration induced by angiotensinⅡ

Rosiglitzone Suppresses Angiotensin II-Induced Production of KLF5 and Cell Proliferation in Rat Vascular Smooth Muscle Cells

PPAR-γ activation by rosiglitazone suppresses angiotensin II-mediated proliferation and phenotypictransition in cardiac fibroblasts via inhibition of activation of activator protein 1.

Effect of Rosiglitazone on the Expression of Endothelin-1 Gene and the Secretion of Tumor Nevrosis Factor-Alpha in Ang Ⅱ-Induced Human Umbilic Vein Endothelial Cells in Vitro

[Effect of Rosiglitazone on the Proliferation and the Production of Transforming Growth Factor-Beta 1 in Cultured Human Tenon' S Capsule Fibroblasts].

Peroxisome Proliferator-Activated Receptor-γ-Agonist Blocked Angiotensin Ⅱ induced Podocyte Injury

Effect of rosiglitazone on the secretion of chemokines in renal tubular epithelial cells stimulated by lipopolysaccharide and the possible mechanism